ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy

Xie, Fengjuan; Tang, Shasha; Zhang, Ye; Zhao, Yinbing; Lin, Yingying; Yao, Yining; Wang, Meiyan*; Gu, Zhengying*; Wan, Jingjing*上海大学; 上海交通大学; 同济大学
ACS Nano2024-1-2DOI: 10.1021/acsnano.3c09968
10阅读
引用收藏
分享

摘要

The combination of immune checkpoint blockade (ICB) and chemotherapy has shown significant potential in the clinical treatment of various cancers. However, circulating regeneration of PD-L1 within tumor cells greatly limits the efficiency of chemo-immunotherapy and consequent patient response rates. Herein, we report the synthesis of a nanoparticle-based PD-L1 inhibitor (FRS) with a rational design for effective endogenous PD-L1 suppression. The nanoinhibitor is achieved through self-assembly of fluoroalkylated competitive peptides that target PD-L1 palmitoylation. The FRS nanoparticles provide efficient protection and delivery of functional peptides to the cytoplasm of tumors, showing greater inhibition of PD-L1 than nonfluorinated peptidic inhibitors. Moreover, we demonstrate that FRS synergizes with chemotherapeutic doxorubicin (DOX) to boost the antitumor activities via simultaneous reduction of PD-L1 abundance and induction of immunogenic cell death in murine colon tumor models. The nano strategy of PD-L1 regulation present in this study is expected to advance the development of ICB inhibitors and overcome the limitations of conventional ICB-assisted chemo-immunotherapy.

学科与关键词

关键词
PD-L1 nanoinhibitorimmune checkpoint blockade (ICB)peptide stabilitydrug deliverycancer chemo-immunotherapy
相关
加载中…
  • Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
    Yin, Shuangneng; Chen, Zhaojun; Chen, Dugang*; Yan, Dan*2023, 13(5): 1520-1544.被引 16
  • Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesis
    Che, Ruijun; Han, Dandan; Wang, Fei; Liu, Huifang; Fan, Miao; Yan, Hongyu; Xiao, Tingshan; Wang, Zhaoshuo; Zhou, Xiaohan; Wang, Xueyi; Zhang, Kaihan; Ou, Caiwen; Zhang, Jinchao*; Li, Zhenhua*Nano Research, 2023, 16(5): 7227-7236.被引 1
  • Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response (Aug, 10.1039/d1nr03288g, 2021)
    Yu, Jie; He, Xidong; Wang, Zigui; Wang, Yupeng; Liu, Sha; Xie, Zhigang; Li, Xiaoyuan*; Huang, Yubin*Nanoscale, 2021, 13(32): 13907-13907.
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS Nano
发表日期
2024-01-02
卷期
第 18 卷, 第 2 期
页码
1690-1701
DOI
10.1021/acsnano.3c09968
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22122404, 22074044, 32171414]; National Natural Science Foundation of China (NSFC) [KF2105]; State Key Laboratory of Oncogenes and Related Genes [23ZR1419500]; Natural Science Foundation of Shanghai [CSTB2022NSCQ-MSX0461]; Natural Science Foundation of Chongqing

作者

  • X

    Xie, Fengjuan (第一作者)

  • T

    Tang, Shasha

    tongji univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Ye

  • Z

    Zhao, Yinbing

  • L

    Lin, Yingying

  • Y

    Yao, Yining

  • W

    Wang, Meiyan (通讯)

    shanghai univ

  • G

    Gu, Zhengying (通讯)

    shanghai jiao tong univ

  • W

    Wan, Jingjing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417